Cantor Fitzgerald, L. P. »

Travere Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2024-09-30 $500k 36k 13.99

More positions owned by Cantor Fitzgerald, L. P.

Spdr S&p 500 Etf Tr Put Put Option
Nvidia Corporation Put Put Option
Tesla Put Put Option
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Call Call Option
Tesla Motors (TSLA)
Nvidia Corporation Call Call Option
Gcm Grosvenor Com Cl A (GCMG)
Rumble Com Cl A (RUM)
Tesla Call Call Option
Proshares Tr Ultrapro Qqq (TQQQ)
Super Micro Computer Put Put Option
Broadcom Put Put Option
Super Micro Computer
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Travere Therapeutics

BlackRock
Woodline Partners
Emerald Advisers
Renaissance Technologies
D. E. Shaw & Co
Bank of America Corporation
Geode Capital Management
Jacobs Levy Equity Management
Assenagon Asset Management
Emerald Mutual Fund Advisers, Trust
Citadel Advisors
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Pictet Asset Management Holding SA
Voloridge Investment Management

View all funds holding Travere Therapeutics